VYNE Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for VYNE Therapeutics stock have an average target of 6.88, with a low estimate of 5.75 and a high estimate of 8.00. The average target predicts an increase of 143.97% from the current stock price of 2.82.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$5.75	$6.88	$8.00	$8.00
Change	+103.90%	+143.97%	+183.69%	+183.69%

Analyst Ratings

The average analyst rating for VYNE stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '24	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24
Strong Buy	1	1	1	1	1	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Julian Harrison BTIG	BTIG	Strong Buy Initiates $8	Strong Buy	Initiates	$8	+183.69%	Nov 18, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5.75	Strong Buy	Reiterates	$5.75	+103.90%	Nov 8, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5.75	Strong Buy	Reiterates	$5.75	+103.90%	Sep 12, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5.75	Strong Buy	Reiterates	$5.75	+103.90%	Aug 15, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5.75	Strong Buy	Reiterates	$5.75	+103.90%	Jun 14, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

561.00K

from 424.00K

32.31%

from 424.00K

Revenue Next Year

n/a

from 561.00K

EPS This Year

-0.62

from -2.78

EPS Next Year

-0.89

from -0.62

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	443.00K	20.99M	931.00K	477.00K	424.00K	561.00K	-	-
Revenue Growth	-87.68%	4,638.83%	-95.57%	-48.76%	-11.11%	32.31%	-	-
EPS	-201.91	-141.90	-25.65	-7.28	-2.78	-0.62	-0.89	-0.79
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	630,000	n/a	n/a
Avg	561,000	n/a	n/a
Low	490,000	n/a	n/a

Revenue Growth

Revenue Growth	2024	2025	2026
High	48.6%	-	-
Avg	32.3%	-	-
Low	15.6%	-	-

EPS Forecast

EPS	2024	2025	2026
High	-0.10	-0.91	-0.81
Avg	-0.62	-0.89	-0.79
Low	-0.89	-0.85	-0.75

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.